Professional Profile
Dr. Nigel Greene is a computational and drug discovery toxicologist in ToxStrategies’ Pharmaceuticals practice. With over thirty years of experience working in computational ADME and toxicology, secondary pharmacology, cheminformatics, medicinal chemistry, new approach methodologies (NAMs), and drug discovery, Dr. Greene is a recognized international expert in his field. His specialties include machine learning (ML) and artificial intelligence (AI), protein modeling, and protein-ligand docking and their applications.
Dr. Greene is a demonstrated leader whose skill with cross-functional team collaboration and working with diverse groups within matrixed management systems has guided pharmaceutical organizations to success. Prior to joining ToxStrategies, Dr. Greene served in senior leadership positions in several large pharmaceutical firms, where he managed ML and AI teams including bioinformatics, drug discovery and preclinical safety teams, providing strategy for early discovery safety testing and other global research and development programs.